US Patent 7488827 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

GSK

Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

Contact Supplier

Evonik Health Care is the innovation hub for leading life science companies

Contact Supplier

Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

Contact Supplier

Axplora is your partner of choice for complex APIs.

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

pharmacompass-2-2026-02-09

GSK

VIRTUAL BOOTH, Contact Details

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 4175 News #PharmaBuzz

Interview #SpeakPharma
Vlog #PharmaReel
Data Compilation #PharmaFlow
4175 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

179 All APIs, 145 USDMF, 24 CEP/COS, 1 JDMF, 29 KDMF, 21 NDC API, 3 VMF, 1 Listed APIs

179 All APIs
145 USDMF
24 CEP/COS
1 JDMF
29 KDMF
21 NDC API
3 VMF
1 Listed APIs

DEVELOPMENTS

2733 Drugs in Development

2733 Drugs in Development

FINISHED DOSAGE FORMULATIONS

3695 FDF Dossiers, 468 FDA Orange Book, 2219 Europe, 514 Canada, 107 Australia, 387 South Africa

3695 FDF Dossiers
468 FDA Orange Book
2219 Europe
514 Canada
107 Australia
387 South Africa

EXCIPIENTS

1 All Excipients, 1 USDMF

1 All Excipients
1 USDMF

INSPECTIONS & REGISTRATIONS

176 FDA, 89 EDQM, 2 WHO-GMP, 3 GDUFA

176 FDA
89 EDQM
2 WHO-GMP
3 GDUFA

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

4 All

01 1GLAXO GRP ENGLAND

02 3GLAXOSMITHKLINE

filter Patent Number Reset all filters

4 All

01 47488827

filter API Patent Reset all filters

4 All

01 4Y

filter FDF Patent Reset all filters

4 All

01 4Y

filter Expiration Date Reset all filters

4 All

01 42027-12-18

01

GLAXOSMITHKLINE

FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE

BioProcess International US West

Not Confirmed

GLAXOSMITHKLINE

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-12-18

FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE

US Patent Number : 7488827

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209482

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-12-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

GLAXO GRP ENGLAND

UMECLIDINIUM BROMIDE

BioProcess International US West

Not Confirmed

GLAXO GRP ENGLAND

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-12-18

UMECLIDINIUM BROMIDE

US Patent Number : 7488827

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 205382

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-12-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

GLAXOSMITHKLINE

UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE

BioProcess International US West

Not Confirmed

GLAXOSMITHKLINE

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-12-18

UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE

US Patent Number : 7488827

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 203975

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-12-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

GLAXOSMITHKLINE

FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE

BioProcess International US West

Not Confirmed

GLAXOSMITHKLINE

BioProcess International US West

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-12-18

FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE

US Patent Number : 7488827

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 209482

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-12-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.